Showing results (1831-1840 of 1,912) with videos related to
Sort By:
Pageof 192
Future Oncology (London, England)|July 29, 2025
ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabineEleni Vrana, Hayley Timmins, Ashley Osborne, et al.Nature Genetics|January 11, 2024
A new genomic framework to categorize pediatric acute myeloid leukemiaMasayuki Umeda, Jing Ma, Tamara Westover, et al.Data in Brief|September 16, 2022
Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitorsJean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.Translational Lung Cancer Research|May 20, 2021
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancerVictoria Foy, Colin R Lindsay, Alexandra Carmel, et al.American Journal of Hypertension|October 7, 2017
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical TrialCarolyn H Still, Carlos J Rodriguez, Jackson T Wright, et al.Clinical Trials (London, England)|June 7, 2014
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)Walter T Ambrosius, Kaycee M Sink, Capri G Foy, et al.Plos One|August 23, 2012
A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulationMichelle L Scalley-Kim, Bruce W Hess, Ryan L Kelly, et al.Cancer Research|September 2, 2000
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study CollaboratorsS A Gayther, K A de Foy, P Harrington, et al.Nature Immunology|June 27, 2025
The prostacyclin receptor PTGIR is a NRF2-dependent regulator of CD8+ T cell exhaustionMichael S Dahabieh, Lisa M DeCamp, Brandon M Oswald, et al.Trials|July 8, 2022
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary careSarah L Alderson, Alexandra Wright-Hughes, Alexander C Ford, et al.Pageof 192